METTL1 and hepatocellular carcinoma: In addition, METTL1‐mediated m7G tRNA modification enhances mRNA translation, as well as accelerates HCC progression and tumourigenesis in vitro and in vivo, suggesting that targeting METTL1 and misregulated tRNA modifications could be a promising strategy for HCC treatment.